IHVR-19029 is a potent inhibitor of endoplasmic reticulum α-glucosidases I and II, with an IC50 of 0.48 μM against ER α-glucosidase I; it effectively blocks the replication of several hemorrhagic fever viruses, including dengue virus, Ebola virus, and Rift Valley fever virus; it enhances antiviral activity when used in combination with Favipiravir (HY-14768).